A drug loophole was closed. Why isn’t it being enforced?
THE BOSTON GLOBE
NOVEMBER 3, 2019
By Juliette Kayyem
One year ago, for a brief moment, political party took a back seat to duty, and a bipartisan Congress passed and the president signed “one of the most consequential pieces of legislation” of 2018. The Synthetics Trafficking and Overdose Protection Act was designed to close a loophole in a post-9/11 security law that has allowed international drug traffickers to easily ship opioids to the United States without detection — and laid out clear deadlines for doing so.Read More >